Compare Medtronic PLC (MDT) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Vital Farms Inc — how do they compare? Medtronic PLC trades at $82.29 (market cap $106.61B), while Vital Farms Inc trades at $13.33 (market cap $590.45M). The key difference: Medtronic PLC is far larger — about 180.6× Vital Farms Inc's market cap, and Medtronic PLC pays a 3.46% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals.
| MDT | VITL | |
|---|---|---|
Market Cap | $106.61B | $590.45M |
Sector | Health | Consumer Staples |
52-Week High | $105.35 | $52.41 |
52-Week Low | $73.75 | $8.28 |
Enterprise Value | $125.36B | $593.26M |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Vital Farms (VITL) trades at $13.76, up 1.55% with a bullish technical signal from moving averages. The company shows solid profitability with 6.1% net margin and 15.44% ROE, though recent earnings missed expectations in two of the last three quarters. Analyst consensus is positive with 56% buy ratings and a $13.50 price target, while news highlights declining short interest and ongoing class action lawsuits.
The stock presents a mixed outlook with strong fundamentals offset by legal risks and earnings volatility. Valuation appears reasonable with P/E of 13.02 and P/S of 0.79, but investors should weigh the class action litigation's potential impact against the company's operational strength in the natural foods sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
